Coya Therapeutics (COYA) Insider Trading & Ownership $6.08 -0.02 (-0.33%) Closing price 04:00 PM EasternExtended Trading$6.06 -0.02 (-0.33%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Coya Therapeutics (NASDAQ:COYA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.00%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$69.61KNumber OfInsiders Selling(Last 12 Months)0 Get COYA Insider Trade Alerts Want to know when executives and insiders are buying or selling Coya Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address COYA Insider Buying and Selling by Quarter Coya Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/14/2024David S SnyderCFOBuy1,800$7.19$12,942.00 11/11/2024Arun SwaminathanCEOBuy5,000$7.34$36,700.00 11/11/2024Fred GrossmanInsiderBuy2,710$7.37$19,972.70 (Data available from 1/1/2013 forward) COYA Insider Trading Activity - Frequently Asked Questions Who is on Coya Therapeutics' Insider Roster? The list of insiders at Coya Therapeutics includes Arun Swaminathan, David S Snyder, and Fred Grossman. Learn more on insiders at COYA. What percentage of Coya Therapeutics stock is owned by insiders? 12.00% of Coya Therapeutics stock is owned by insiders. Learn more on COYA's insider holdings. Which Coya Therapeutics insiders have been buying company stock? The following insiders have purchased COYA shares in the last 24 months: Arun Swaminathan ($36,700.00), David S Snyder ($12,942.00), and Fred Grossman ($19,972.70). How much insider buying is happening at Coya Therapeutics? Insiders have purchased a total of 9,510 COYA shares in the last 24 months for a total of $69,614.70 bought. Coya Therapeutics Key ExecutivesDr. Howard Berman Ph.D. (Age 50)Chairman & CEO Compensation: $833.75kDr. Fred Grossman D.O. (Age 62)FAPA, President & Chief Medical Officer Compensation: $610.63kMr. David S. Snyder (Age 64)CFO & COO Compensation: $610.94kDr. Gregory MacMichael Ph.D. (Age 68)Chief Technical Officer Dr. Michelle Frazier Ph.D.Senior Vice President of Regulatory AffairsMr. Aaron Thome Ph.D.Head of Neuroinflammation PlatformDr. Arun Swaminathan Ph.D.Chief Business Development Officer More Insider Trading Tools from MarketBeat Related Companies Palvella Therapeutics Insider Buying REGENXBIO Insider Buying Tectonic Therapeutic Insider Buying Fulcrum Therapeutics Insider Buying Kodiak Sciences Insider Buying COMPASS Pathways Insider Buying Aquestive Therapeutics Insider Buying iTeos Therapeutics Insider Buying Eton Pharmaceuticals Insider Buying Vigil Neuroscience Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:COYA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
